Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
3
×
biotech
boston
boston blog main
boston top stories
clinical trials
national blog main
ally bridge group
big data analytics
biology
biotech ipos
biotechnology
blackrock
california
cambridge
casdin capital
crispr
diabetic nephropathy
dna
dyne therapeutics
emerging-technologies
eventide asset management
fda
focal segmental glomerulosclerosis
george church
goldfinch bio
harvard university
healthcare
idinvest partners
irving investors
jay ghosh
massachusetts institute of technology
metacrine
myotonic dystrophy type 1
national top stories
nonalcoholic steatohepatitis
paris
rare disease drugs
rare diseases
salk institute
What
genetic
3
×
million
3
×
raised
company
drug
ipo
medicines
new
agriculture
analysis
big
bio
biology
biotech
bring
brings
claims
commercialize
develop
developing
diseases
disorders
dna
dyne
dyne’s
employing
equally
faster
financing
forward
goldfinch
important
industries
kidney
later
lead
leap
make
manufacturing
material
Language
unset
Current search:
million
×
" life sciences "
×
genetic
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@techcrunch.com
5 years ago
DNA Script picks up $38.5 million to make DNA production faster and simpler
